1. Knockdown of circBFAR inhibits proliferation and glycolysis in gastric cancer by sponging miR-513a-3p/hexokinase 2 axis.
- Author
-
Wang, Yuning, Cao, Bo, Zhao, Ruiyang, Li, Hanghang, Wei, Bo, and Dai, Guanghai
- Subjects
- *
STOMACH cancer , *GLYCOLYSIS , *CIRCULAR RNA , *OXYGEN consumption , *CELL proliferation , *CELL lines - Abstract
The relationship between circular RNAs (circRNAs) and many types of cancer has been of great interest. A novel circRNA, circBFAR, has been identified, but the functions of circBFAR and its underlying mechanism in gastric cancer (GC) have not been reported. This study was designed to investigate the role of circBFAR in GC and its downstream miRNA targets. Quantitative real-time polymerase reaction was used to detect the expression of circBFAR and miRNAs. Cell counting kit-8 and EdU were used to detect the proliferation of GC cells. Measurement of the extracellular acidification rate, oxygen consumption rate and lactate acid production were performed to assess the glycolysis levels. The results showed that circBFAR exhibited higher expression in GC tissues and cell lines. circBFAR was proven to promote GC proliferation by targeting the miR-513a-3p/hexokinase 2 (HK2) axis. Inhibition of circBFAR also led to a significant decrease in the glycolysis levels. In this study, we found a circBFAR/miR-513a-3p/HK2 axis in GC and revealed the relationship between circBFAR and glycolysis for the first time. circBFAR may serve as a novel target of GC individualized therapy. • Identification of the circBFAR functions in proliferation of gastric cancer. • miR-513a-3p/hexokinase 2 axis as the critical target of circBFAR. • Glycolysis driven by circBFAR in gastric cancer. • Potentials of circBFAR knockdown in the treatment of gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF